Valeant's stock soars after profit beats expectations
Shares of Valeant Pharmaceuticals International Inc. soared 11% in premarket trade Tuesday, after the drug maker beat first-quarter profit expectations, although revenue came up shy. The company swung to a net profit of $628 million, or $1.79 a share, from a loss of $374 million, or $1.08 a share, in the same period a year ago. The FactSet consensus was for earnings per share of 87 cents. Revenue fell to $2.11 billion from $2.37 billion, missing the FactSet consensus of $2.18 billion, as product... Читать дальше...